Life Sciences US roadshow
October 2016
A high-level Manchester-based business delegation is visiting the US as part of a roadshow taking place in Minneapolis, Chicago and Boston.
The roadshow, which is supported by UKTI, aims to promote Greater Manchester’s health innovation capabilities as well as facilitating trade, investment and R&D collaborations.
The roadshow coincides with the AdvaMed MedTech 2016 Conference, which is taking place in Minneapolis from 17-19 October, at which Corridor Manchester Health Innovation, represented by Professor Jackie Oldham (Director of Corridor Manchester Health Innovation) will have a presence on stand N424.
Manchester has long been at the forefront of Innovation, and Corridor Manchester has a strong history of Health Innovation including 'world firsts' - such as the invention of the bionic eye.
If you are attending AdvaMed 2016 please come along to stand N424 to say hello to Professor Oldham, and find out more about Corridor Manchester Health Innovation.
A high-level Manchester-based business delegation is visiting the US as part of a roadshow taking place in Minneapolis, Chicago and Boston.
The roadshow, which is supported by UKTI, aims to promote Greater Manchester’s health innovation capabilities as well as facilitating trade, investment and R&D collaborations.
The roadshow coincides with the AdvaMed MedTech 2016 Conference, which is taking place in Minneapolis from 17-19 October, at which Corridor Manchester Health Innovation, represented by Professor Jackie Oldham (Director of Corridor Manchester Health Innovation) will have a presence on stand N424.
Manchester has long been at the forefront of Innovation, and Corridor Manchester has a strong history of Health Innovation including 'world firsts' - such as the invention of the bionic eye.
If you are attending AdvaMed 2016 please come along to stand N424 to say hello to Professor Oldham, and find out more about Corridor Manchester Health Innovation.
- Manchester is a globally competitive life science destination with a comprehensive health innovation system that provides significant opportunities for collaboration and investment
- Manchester is one of Europe’s leading business destinations with strengths in research and life sciences, which have seen immeasurable growth over recent years
- Life science and healthcare plays an important role in Manchester, and this year, two sites within the Corridor Manchester area were awarded Enterprise Zone status
- The city has a world-class talent pool, access to markets and a competitive cost base
- It is the only UK city region to integrate health and social care and have devolved control of its £6 billion healthcare budget
- The opportunity that devolution presents; local commissioning, direct access to one of the largest National Health Services (NHS) clusters in the UK, an enhanced digital-health infrastructure and world-leading informatics research
- Manchester - home of innovation, more working Nobel Prize-winners than Oxford and Cambridge combined and is the city of choice for more than 200 biomedical companies and is the city , is the city of choice
- Manchester Science Partnerships (MSP), based within the Corridor Manchester area is home to a community of scientists, innovators, investors and entrepreneurs with over 170 companies in the life science, biotechnology, ICT and digital creative sectors onsite
- Manchester’s heritage in innovation and science meant the city was designated European City of Science in 2016
